Kevin Nguyen

Kevin Nguyen has a diverse background in various sectors, primarily in the biotechnology and investment fields. Most recently, they worked as part of the Business Development & Strategy team at Apogee Therapeutics. Kevin was responsible for advancing novel therapies for immunological and inflammatory disorders. Prior to that, they had a brief stint in Corporate Development at Gilead Sciences. Kevin also gained experience in Venture Capital at 5AM Ventures and in Investment Banking at Evercore.

Kevin Nguyen has a Master of Business Administration (MBA) degree with a specialization in Health Care Management from The Wharton School. Kevin also holds a Bachelor's degree from the University of Southern California, where they studied Biological Sciences and Economics.